226 related articles for article (PubMed ID: 18253057)
1. Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia.
Pillai A
Neurosignals; 2008; 16(2-3):183-93. PubMed ID: 18253057
[TBL] [Abstract][Full Text] [Related]
2. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
Pillai A; Veeranan-Karmegam R; Dhandapani KM; Mahadik SP
J Neurochem; 2008 Nov; 107(4):941-51. PubMed ID: 18786174
[TBL] [Abstract][Full Text] [Related]
3. TrkB partial agonists: potential treatment strategy for major depression.
Tsai SJ
Med Hypotheses; 2007; 68(3):674-6. PubMed ID: 16905274
[TBL] [Abstract][Full Text] [Related]
4. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
5. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.
Hashimoto T; Bergen SE; Nguyen QL; Xu B; Monteggia LM; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2005 Jan; 25(2):372-83. PubMed ID: 15647480
[TBL] [Abstract][Full Text] [Related]
6. The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex.
Rantamäki T; Knuuttila JE; Hokkanen ME; Castrén E
Neuropharmacology; 2006 Mar; 50(4):421-7. PubMed ID: 16300803
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
Lee BH; Kim YK
Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains.
Iritani S; Niizato K; Nawa H; Ikeda K; Emson PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):801-7. PubMed ID: 12921913
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview.
Lebrun B; Bariohay B; Moyse E; Jean A
Auton Neurosci; 2006 Jun; 126-127():30-8. PubMed ID: 16632412
[TBL] [Abstract][Full Text] [Related]
10. [New pharmacological approaches to the treatment of schizophrenia].
Uzbay IT
Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
[TBL] [Abstract][Full Text] [Related]
11. [Effects of TrkB-BDNF signal pathway on synthesis and secretion of vascular endothelial growth factor in human neuroblastoma cells].
Li KX; Li AM; Zhang JH
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):240-3. PubMed ID: 21426646
[TBL] [Abstract][Full Text] [Related]
12. Lower serum tropomyosin receptor kinase B levels in patients with schizophrenia.
Hung YY; Huang TL
Biomed J; 2013; 36(3):132-6. PubMed ID: 23806883
[TBL] [Abstract][Full Text] [Related]
13. Interaction of sex steroid hormones and brain-derived neurotrophic factor-tyrosine kinase B signalling: relevance to schizophrenia and depression.
Hill RA
J Neuroendocrinol; 2012 Dec; 24(12):1553-61. PubMed ID: 22845879
[TBL] [Abstract][Full Text] [Related]
14. Neonatal maternal separation increases brain-derived neurotrophic factor and tyrosine kinase receptor B expression in the descending pain modulatory system.
Chung EK; Bian ZX; Xu HX; Sung JJ
Neurosignals; 2009; 17(3):213-21. PubMed ID: 19546592
[TBL] [Abstract][Full Text] [Related]
15. BDNF in schizophrenia, depression and corresponding animal models.
Angelucci F; Brenè S; Mathé AA
Mol Psychiatry; 2005 Apr; 10(4):345-52. PubMed ID: 15655562
[TBL] [Abstract][Full Text] [Related]
16. BDNF-TrkB signaling and neuroprotection in schizophrenia.
Pandya CD; Kutiyanawalla A; Pillai A
Asian J Psychiatr; 2013 Feb; 6(1):22-8. PubMed ID: 23380313
[TBL] [Abstract][Full Text] [Related]
17. Recovery of whisking function after manual stimulation of denervated vibrissal muscles requires brain-derived neurotrophic factor and its receptor tyrosine kinase B.
Söhnchen J; Grosheva M; Kiryakova S; Hübbers CU; Sinis N; Skouras E; Ankerne J; Kaidoglou K; Fries JW; Irintchev A; Dunlop SA; Angelov DN
Neuroscience; 2010 Sep; 170(1):372-80. PubMed ID: 20600640
[TBL] [Abstract][Full Text] [Related]
18. [Brain-derived neurotrophic factor and psychiatric diseases].
Kojima M
Tanpakushitsu Kakusan Koso; 2007 Jul; 52(8):900-5. PubMed ID: 17642274
[No Abstract] [Full Text] [Related]
19. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
Guillin O; Demily C; Thibaut F
Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
[TBL] [Abstract][Full Text] [Related]
20. TrkB inhibition as a therapeutic target for CNS-related disorders.
Boulle F; Kenis G; Cazorla M; Hamon M; Steinbusch HW; Lanfumey L; van den Hove DL
Prog Neurobiol; 2012 Aug; 98(2):197-206. PubMed ID: 22705453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
